This trial will see if the CARES intervention (Cancer Advocacy, Resources, Education and Support) can help improve treatment times for lung and head & neck cancer patients.
1 Primary · 2 Secondary · Reporting Duration: From study start to study end (6 months)
320 Total Participants · 2 Treatment Groups
Primary Treatment: CARES Intervention · No Placebo Group · N/A
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: